Doctors issue warning against common anti-allergy medicine
Anti-allergy may have more side effects than advantages
Doctors are now speaking up against over-the-counter (OTC) anti-allergy medicine claiming that its risk are more than benefits.
Millions of adults and children take OTC diphenhydramine, the active ingredient in Benadryl, for allergies or for its drowsiness effect to help with sleep.
It is one of the most recognizable allergy medicines on pharmacy shelves as its famous for calming down symptoms such as allergy-related runny nose, sneezing, itchiness and watery eyes.
But internal medicine physicians argue that the FDA should eliminate the over-the-counter medicine from the US market based on concerns about potentially severe adverse effects, which includes “substantial” brain damage.
What is diphenhydramine?
Diphenhydramine is a first-generation antihistamine (anti-allergy) that easily enters the brain, where it causes strong drowsiness and impairs alertness and coordination.
This sedation can reduce work productivity, hurt school performance and significantly increase the risk of car accidents. In some tests, its effects on driving were more severe than being over the legal alcohol limit.
Beyond sleepiness, diphenhydramine also causes a range of uncomfortable and sometimes dangerous side effects, including dry mouth, constipation, blurred vision, confusion and urinary difficulty, which are especially risky for older adults. Young people have also overdosed on this drug.
What do we use instead of Benadryl?
Newer antihistamines, like fexofenadine, used in Allegra, and loratadine, used in Claritin, developed in the late 20th century, offer equal allergy relief with fewer side effects and longer-lasting action.
-
What to know before using weight-loss drugs like Ozempic
-
Singapore confirms first local spread of mutated monkeypox clade Ib strain
-
World Autism Awareness Day: Celebrating different minds, shaping a shared future
-
Some grief never goes away—Scientists now know why
-
E-cigarettes: A proving quitting tool that still carries health risks
-
Eli Lilly expands $2.75B AI-enabled drug discovery deal with Insilico Medicine
-
London sewage detects polio weeks after funding drop
-
COVID-19 ‘Cicada’ variant: Here’s everything to know
-
Eye drops made from pig body fluid could revolutionize cancer treatment, new study says
-
Paul Conyngham uses ChatGPT, AlphaFold to develop a life-saving cancer vaccine for his dog
-
'Cicada' COVID variant detected in multiple countries as experts study mutation risks
-
Metformin’s hidden brain pathway uncovered after 60 years
